Am J Transplant, Volume 17, Suppl 3 Archives - Page 97 of 181 - ATC Abstracts

2017 American Transplant Congress
Non-Directed Kidney Donor Candidate Referral, Care, and Attrition in an Online Portal.
R. Hays,¹ K. Schappe,¹ D. Kaufman,¹ D. Mandelbrot.²
¹Division of Transplant Surgery, University of Wisconsin Hospital and Clinics, Madison, WI; ²Division of Nephrology, Department of Medicine, University of Wisconsin Hospital and Clinics, Madison, WI
When non-directed live kidney donation (NDD) was first described in the early 2000s, a high rate of inquiry per actual donor was noted. Since then,…
2017 American Transplant Congress
Perceived Patient Barriers for Kidney Transplant Evalution Among Transplant Center Staff.
L. McPherson, K. Lipford, R. Hamoda, J. Gander, S. Pastan, R. Patzer.
Emory University, Atlanta, GA
Background: The Southeastern United States has the lowest rates of kidney transplant in the nation. Disparities in transplant access among end stage renal disease (ESRD)…
2017 American Transplant Congress
Lung Preservation Solution Exposure at Cardiac Procurement Is Associated Increased Incidence of Coronary Arterial Vasculopathy.
H. Copeland,¹ V. Garcia,² A. Sima,² D. Baran,³ A. Mankind,⁴ G. Katlaps,¹ N. Lewis,⁴ B. Dharmaj,¹ J. Copeland.⁵
¹Cardiothoracic Surgery, McGuire VA Medical Center, Richmond, VA; ²Biostatistics, Virginia Commonwealth University, Richmond, VA; ³Cardiology, Beth Israel Medical Center Barnabas Health, Newark, NJ; ⁴Cardiology, McGuire VA Medical Center, Richmond, VA; ⁵Surgery, Division of Cardiothoracic Surgery, University of Arizona, Tucson, AZ
Purpose: To evaluate cardiac recipient survival and incidence of coronary artery vasculopathy (CAV) in recipient hearts that have been exposed to lung preservation solution, Perfadex.Methods:…
2017 American Transplant Congress
Exploring Differential Antibody Response to Bortezomib in Heart Transplantation.
K. Ghafourian, R. Hod-Dvorai, S. McCabe, N. Cool, M. Fine, M. Ackerman, J. Rich, J. Wilcox, E. Vorovich, A. Anderson, A. Tambur.
Northwestern University, Chicago, IL
Twelve heart transplant candidates (2013-2016) received Bortezomib (BTZ) for desensitization. Differential antibody (Ab) response was observed. BTZ cycles consisted of 4 injections of 1.3 mg/m2;…
2017 American Transplant Congress
CD16+ Monocytes and Skewed Macrophage Polarization Towards M2 Type Hallmark Heart Transplant Acute Cellular Rejection.
T. van den Bosch,¹ K. Caliskan,² M. Kraaij,¹ A. Constantinescu,² O. Manintveld,² P. Leenen,³ J. von der Thüsen,⁴ M. Clahsen-van Groningen,⁴ C. Baan,¹ A. Rowshani.¹
¹Internal Medicine and Transplantation, Erasmus University Medical Center, Rotterdam, Netherlands; ²Cardiology, Erasmus University Medical Center, Rotterdam, Netherlands; ³Immunology, Erasmus University Medical Center, Rotterdam, Netherlands; ⁴Pathology, Erasmus University Medical Center, Rotterdam, Netherlands
Purpose: During acute heart transplant rejection, infiltration of lymphocytes and monocytes is followed by endothelial injury and eventually myocardial fibrosis. To date, no information is…
2017 American Transplant Congress
Renal Function, Albuminuria, and the Risk of Death and Graft Loss After Kidney Transplantation.
N. Lam,¹ M. Tonelli,² K. Lentine,³ B. Hemmelgarn,² F. Ye,¹ K. Wen,¹ S. Klarenbach.¹
¹University of Alberta, Edmonton, Canada; ²University of Calgary, Calgary, Canada; ³Saint Louis University, St. Louis
In 2012, the KDIGO guidelines updated the classification system for chronic kidney disease to include albuminuria. Whether this classification system prognosticates adverse clinical outcomes among…
2017 American Transplant Congress
Building a Conceptual Framework of Treatment Burden After Kidney Transplant: A Qualitative Study.
E. Lorenz, J. Egginton, M. Stegall, A. Cheville, D. Eton.
Mayo Clinic, Rochester
Background: After kidney transplant, patients must negotiate complex medication regimens, lifestyle changes, laboratory monitoring and clinic appointments. The personal workload of healthcare and its impact…
2017 American Transplant Congress
Scoring of Distinct Tubular Injury Features and Assessment of Cellular Proliferation and of Non-Apoptotic Cell Death by the Novel Marker FACL4 Allow to Determine the Long-Term Prognosis of Renal Grafts.
A. Bohlmann,¹ J. Schmitz,¹ A. Melk,¹ R. Schmitt,¹ I. Scheffner,¹ V. Broeker,² H. Haller,¹ J. Metzger,³ J. Braesen,¹ W. Gwinner.¹
¹Hannover Medical School, Hannover, Germany; ²University of Gothenburg, Gothenburg, Sweden; ³Mosaiques Diagnostics, Hannover, Germany
Acute tubular injury (ATI) is common in renal grafts and is related to an inferior long-term function. There is no consensus which of the tubular…
2017 American Transplant Congress
Regional Variation in Liver Donor Utilization Across the U.S.
A. Friedman,¹ P. Bagavan,² S. Florman,³ H. Irving,¹ B. Samstein,⁴ B. Schleich.¹
¹LiveOnNY, New York, NY; ²Binghamton University, Binghamton, NY; ³Recanati/Miller Transplant Institute, New York, NY; ⁴Weill Cornell Medical College, New York, NY
Unequal patient access to deceased donor liver transplantation across the U.S. has generated efforts to redesign the allocation system. Geographic disparities include the severity of…
2017 American Transplant Congress
Outcomes of Moderately to Severely Steatotic Grafts in Liver Transplantation: A Meta-Analysis.
K. Bonner,¹ C. Thongprayoon,² W. Cheungpasitporn,¹ M. Leise.¹
¹Mayo Clinic, Rochester; ²Bassett Medical Center, Cooperstown
Background/Objectives:There is a worldwide need to expand the pool of available liver grafts. Livers with >50% steatosis are discarded for orthotopic liver transplantation (OLT) by…